Patients With End-Stage Renal Disease, Atrial Fibrillation Have Unique Considerations When Starting Anticoagulation Therapy

In an interview with Pharmacy Times, Zachary Noel, PharmD, BCCP, discussed the presentation at the American Society of Health-System Pharmacists 2021 Midyear Meeting titled "Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease."

In the interview, Noel discussed specific considerations for patients with end-stage renal disease and atrial fibrillation, recommendations for anticoagulation initiation, and how to best assess stroke risk in these populations.